Aflac Incorporated has announced an increase in its share repurchase authorization, with its Board of Directors approving the purchase of up to 100 million additional shares of its common stock. This expands the existing authorization, which had 30.9 million shares remaining as of June 30, 2025, under the previous November 8, 2022 authorization, bringing the total number of shares available for repurchase to approximately 130.9 million. The repurchase is expected to occur through open market or negotiated transactions, contingent on market conditions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.